… as the pipeline embolisation device (Medtronic Neurovascular, Irvine, California), to treat
AVFs and inhibit fistula recanalisation in special scenarios,14 as described by Castãno et al …

… Kinouchi et al. and Kai et al. observed patients who experienced recurrent SAH from one
lesion over several years [17], [18]. Overall, efficient diagnosis and definitive treatment appear …

… For instance, Raymond et al's4 experience with 501 cerebral aneurysms treated with
endovascular coiling demonstrated that complete angiographic occlusion rate was …

OBJECTIVE: The response to shunt surgery for idiopathic normal-pressure hydrocephalus (INPH)
is variable because INPH is difficult to distinguish from other conditions causing the …

Background and Purpose— Cerebral vasospasm remains a major source of morbidity after
aneurysmal subarachnoid hemorrhage (SAH). We demonstrate that simvastatin reduces …

Object. Image-guided stereotactic brain biopsy is associated with transient and permanent
incidences of morbidity in 9 and 4.5% of patients, respectively. The goal of this study was to …

Introduction The Woven EndoBridge Intrasaccular Therapy (WEB-IT) Study is a pivotal,
prospective, single-arm, investigational device exemption study designed to evaluate the safety …

OBJECTIVE: Clinical and experimental evidence suggests that hyperglycemia lowers the
neuronal ischemic threshold, potentiates stroke volume in focal ischemia, and is associated …

… inclusion within the aneurysm fundus, although the relevant anatomical parameters have
been variably defined.On the more restrictive end of the spectrum, Kan et al. studied 701 PED …

… Kallmes et al 8 reported the overall rate of major morbidity and neurological mortality was
7.1% in their pooled analysis of PED studies. In SCENT, the combined rate of disabling stroke …